Assay Development and HTS Screening Scientist
DefiniGEN is an exciting, high growth Cambridge stem cell biotechnology company supported by the University of Cambridge who aim to become a market leader in the provision of stem cell products and services to the pharmaceutical sector. DefiniGEN main technology OptiIDIFF enables the differentiation of human IPSC into liver hepatocyte, pancreatic and intestinal cells for disease modelling and drug screening. We are currently looking to recruit a talented HTS Scientist to join our R&D Team and develop our screening capabilities to deliver innovative tools for drug discovery.
To be considered for this opportunity you will possess up-to-date, hands-on experience in compound screening, high content imaging, automation and phenotypic screening preferably in the life science or stem cell sectors. Successful delivery of HTS projects coupled with excellent verbal and written communication skills will be necessary as well as the ability to interface well with colleagues and clients.
Applicants should apply by cover letter and CV to: firstname.lastname@example.org